Skip to main content
Log in

Predictive Accuracy of the PanCan Lung Cancer Risk Prediction Model -External Validation based on CT from the Danish Lung Cancer Screening Trial

  • Chest
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objectives

Lung cancer risk models should be externally validated to test generalizability and clinical usefulness. The Danish Lung Cancer Screening Trial (DLCST) is a population-based prospective cohort study, used to assess the discriminative performances of the PanCan models.

Methods

From the DLCST database, 1,152 nodules from 718 participants were included. Parsimonious and full PanCan risk prediction models were applied to DLCST data, and also coefficients of the model were recalculated using DLCST data. Receiver operating characteristics (ROC) curves and area under the curve (AUC) were used to evaluate risk discrimination.

Results

AUCs of 0.826–0.870 were found for DLCST data based on PanCan risk prediction models. In the DLCST, age and family history were significant predictors (p = 0.001 and p = 0.013). Female sex was not confirmed to be associated with higher risk of lung cancer; in fact opposing effects of sex were observed in the two cohorts. Thus, female sex appeared to lower the risk (p = 0.047 and p = 0.040) in the DLCST.

Conclusions

High risk discrimination was validated in the DLCST cohort, mainly determined by nodule size. Age and family history of lung cancer were significant predictors and could be included in the parsimonious model. Sex appears to be a less useful predictor.

Key points

• High accuracy in logistic modelling for lung cancer risk stratification of nodules.

• Lung cancer risk prediction is primarily based on size of pulmonary nodules.

• Nodule spiculation, age and family history of lung cancer are significant predictors.

• Sex does not appear to be a useful risk predictor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

AUC:

Area under the curve

BCCA:

British Columbia Cancer Agency

CT:

Computed tomography

DLCST:

Danish Lung Cancer Screening Trial

NLST:

National Lung Screening Trial

OR:

Odds ratio

PanCan:

Pan-Canadian Early Detection of Lung Cancer Study

ROC:

Receiver operating characteristics

SD:

Standard deviation

References

  1. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 2:74–108

    Article  Google Scholar 

  2. Aberle DR, Adams AM, Berg CD et al (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 5:395–409

    Google Scholar 

  3. Bach PB, Mirkin JN, Oliver TK et al (2012) Benefits and harms of CT screening for lung cancer: a systematic review. JAMA 22:2418–2429

    Article  Google Scholar 

  4. Bach PB, Kattan MW, Thornquist MD et al (2003) Variations in lung cancer risk among smokers. J Natl Cancer Inst 6:470–478

    Article  Google Scholar 

  5. Spitz MR, Hong WK, Amos CI et al (2007) A risk model for prediction of lung cancer. J Natl Cancer Inst 9:715–726

    Article  Google Scholar 

  6. Spitz MR, Etzel CJ, Dong Q et al (2008) An expanded risk prediction model for lung cancer. Cancer Prev Res (Phila) 4:250–254

    Article  Google Scholar 

  7. Cassidy A, Myles JP, Liloglou T, Duffy SW, Field JK (2006) Defining high-risk individuals in a population-based molecular-epidemiological study of lung cancer. Int J Oncol 5:1295–1301

    Google Scholar 

  8. Tammemagi CM, Pinsky PF, Caporaso NE et al (2011) Lung cancer risk prediction: prostate, lung, colorectal and ovarian cancer screening trial models and validation. J Natl Cancer Inst 13:1058–1068

    Article  Google Scholar 

  9. Swensen SJ, Silverstein MD, Ilstrup DM, Schleck CD, Edell ES (1997) The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules. Arch Intern Med 8:849–855

    Article  Google Scholar 

  10. Gould MK, Ananth L, Barnett PG (2007) A clinical model to estimate the pretest probability of lung cancer in patients with solitary pulmonary nodules. Chest 2:383–388

    Article  Google Scholar 

  11. Li Y, Wang J (2012) A mathematical model for predicting malignancy of solitary pulmonary nodules. World J Surg 4:830–835

    Article  Google Scholar 

  12. McWilliams A, Tammemagi MC, Mayo JR et al (2013) Probability of cancer in pulmonary nodules detected on first screening CT. N Engl J Med 10:910–919

    Article  Google Scholar 

  13. Wille MM, Thomsen LH, Dirksen A et al (2014) Emphysema progression is visually detectable in low-dose CT in continuous but not in former smokers. Eur Radiol 24:2692–2699

    Article  PubMed  Google Scholar 

  14. Pedersen JH, Ashraf H, Dirksen A et al (2009) The Danish randomized lung cancer CT screening trial–overall design and results of the prevalence round. J Thorac Oncol 5:608–614

    Article  Google Scholar 

  15. Tas F, Ciftci R, Kilic L, Karabulut S (2013) Age is a prognostic factor affecting survival in lung cancer patients. Oncol Lett 5:1507–1513

    Google Scholar 

  16. Cote ML, Liu M, Bonassi S et al (2012) Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the International Lung Cancer Consortium. Eur J Cancer 13:1957–1968

    Article  Google Scholar 

  17. Pauk N, Kubik A, Zatloukal P, Krepela E (2005) Lung cancer in women. Lung Cancer 1:1–9

    Article  Google Scholar 

  18. Belani CP, Marts S, Schiller J, Socinski MA (2007) Women and lung cancer: epidemiology, tumor biology, and emerging trends in clinical research. Lung Cancer 1:15–23

    Article  Google Scholar 

  19. Mizuno S, Takiguchi Y, Fujikawa A et al (2009) Chronic obstructive pulmonary disease and interstitial lung disease in patients with lung cancer. Respirology 3:377–383

    Article  Google Scholar 

  20. Wilson DO, Weissfeld JL, Balkan A et al (2008) Association of radiographic emphysema and airflow obstruction with lung cancer. Am J Respir Crit Care Med 7:738–744

    Article  Google Scholar 

Download references

Acknowledgments

The scientific guarantor of this publication is Asger Dirksen. The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article. Bram Van Ginneken works for Fraunhofer MEVIS in Bremen, Germany. This study has received funding by The Danish Ministry of Health and AstraZeneca. One of the authors has significant statistical expertise. Institutional review board approval was obtained. Written informed consent was obtained from all subjects (patients) in this study. Some study subjects have been previously reported in DLCST studies regarding lung cancer screening, lung function, lung density, airway segmentation, and visual assessment of emphysema, airway abnormalities and interstitial abnormalities in the Danish Lung Cancer Screening Trial. However, analyses of this study are new and have not been published before. All relevant references are disclosed. Methodology: prospective, diagnostic study, performed at two institutions.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mathilde M. Winkler Wille.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Winkler Wille, M.M., van Riel, S.J., Saghir, Z. et al. Predictive Accuracy of the PanCan Lung Cancer Risk Prediction Model -External Validation based on CT from the Danish Lung Cancer Screening Trial. Eur Radiol 25, 3093–3099 (2015). https://doi.org/10.1007/s00330-015-3689-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-015-3689-0

Keywords

Navigation